94697 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4 Oxygen atoms
COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#23,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof
#3FLAVONOID DERIVATIVES WITH GABAA RECEPTOR ACTIVITY AND METHODS OF USE
#4COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#5Small Molecule Inhibitors of PBRM1-BD2
#6DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS
#7Substituted imidazoles for preventing and/or treating cell or tissue necrosis
#8ANTI-BLUE LIGHT COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF
#9Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis
#10Process for the preparation of Deferasirox
#11Process methods for phosphatidylinositol 3-kinase inhibitors
#12Histone acetyltransferase activators and uses thereof
#13Methods and compositions for inhibition of bromodomain-containing proteins
#142,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
#15Process methods for phosphatidylinositol 3-kinase inhibitors
#16Heterocyclic compound
#17Histone Acetyltransferase Activators and Uses Thereof
#18Spiroquinone derivative compound, production method thereof, and pharamaceutical composition for preventing or treating neurological disorders which contains same as active ingredient
#19Substituted thiazoles for preventing and/or treating cell or tissue necrosis
#202,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
#21Process methods for phosphatidylinositol 3-kinase inhibitors
#22Methods and compositions for inhibition of bromodomain-containing proteins
#23Heterocyclic compound
#24Benzoxazinone derivatives for treatment of skin diseases
#25HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
#26Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
#27Benzoxazinone derivatives for treatment of skin diseases
#28Heterocyclic compound
#29Fused heterocyclic compounds as ion channel modulators
#30Methods and compositions for inhibition of bromodomain-containing proteins
#31Process for the preparation of deferasirox
#32Fused heterocyclic compounds as ion channel modulators
#33Fused ring analogues of anti-fibrotic agents
#34Optical film, circularly polarizing plate, and image display device
#35Therapeutic compounds
#36Process for the preparation, of 2-(2-hydroxyphenyl)-benz [1, 3] oxazin-4-one and its use for preparation of 4-[3, 5-bis (2-hydroxyphenyl)-IH-I, 2, 4-triazolTI-yl] benzoic acid
#37Fused ring analogues of anti-fibrotic agents
#38Polymerizable compound, polymerizable liquid crystalline composition, macromolecular compound and film
#39Fused heterocyclic compounds as ion channel modulators
#40FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
#41PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF
#42BENZOXAZINONE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#43Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
#44LIGHTING UNIT COVER
#45QUINAZOLINE-CONTAINING KITS FOR LABELING ALDEHYDE OR KETONE MOIETIES
#46Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors
#47Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#48Method for preparing 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]-benzoic acid
#49Therapeutic compounds
#50O-SUBSTITUTED HYDROXYARYL DERIVATIVES
#51Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#52N-Phenyl Benzamide Derivatives as Sirtuin Modulators
#53Organic fluorescent sulfonyl ureido benzoxazinone pigments
#54Process for preparing a benzoxazinone
#55Substituted dihydroquinazolines as platelet ADP receptor inhibitors
#56Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers
#57Isobenzoxazinones And Their Use As Ultraviolet Light Absorbers
#58Ultraviolet light absorbers
#593-methanesulfonylquinolines as GABAenhancers
#60Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#61Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#62O-substituted hydroxyaryl derivatives
#63Method of preparing alkylated salicylamides via a dicarboxylate intermediate
#64Aryl-ureido benzoxazinone compounds
#65Quinazoline-containing kits for labeling aldehyde or ketone moieties